首页 | 本学科首页   官方微博 | 高级检索  
     

米非司酮治疗腹腔镜术后子宫内膜异位症的疗效观察
引用本文:李俊英. 米非司酮治疗腹腔镜术后子宫内膜异位症的疗效观察[J]. 中国药房, 2011, 0(24): 2282-2283
作者姓名:李俊英
作者单位:浙江象山县红十字台胞医院;
摘    要:目的:观察米非司酮治疗腹腔镜术后子宫内膜异位症的疗效及安全性。方法:72例子宫内膜异位症患者均采用腹腔镜手术,术后随机均分成A组(采用米非司酮12.5mg,qd,连服3个月)和B组(采用孕三烯酮2.5mg,每周2次,连服3个月),比较2组的疗效及不良反应。结果:A组治疗后的缓解率及改善率与B组比较,差异无统计学意义(P>0.05),但A组的复发率明显低于B组(P<0.05),且治疗后痤疮、不规则阴道出血、转氨酶异常、体重增加等不良反应发生率明显低于B组,2组比较差异有统计学意义(P<0.05)。结论:米非司酮治疗腹腔镜术后子宫内膜异位症效果较好,可以降低复发率,且不良反应小。

关 键 词:腹腔镜  子宫内膜异位症  孕三烯酮  米非司酮

Efficacy Observation of Therapy of Mifepristone after Endometriosis Laparoscopic Surgery
LI Jun-ying. Efficacy Observation of Therapy of Mifepristone after Endometriosis Laparoscopic Surgery[J]. China Pharmacy, 2011, 0(24): 2282-2283
Authors:LI Jun-ying
Affiliation:LI Jun-ying(Xiangshan County Red Cross and Taiwan Compatriot Hospital of Zhejiang Province,Ningbo 315731,China)
Abstract:OBJECTIVE: To observe the therapeutic efficacy and safety of mifepristone after the laparoscopic surgery of endometriosis. METHODS: 72 patients received laparoscopic surgery. All patients were randomly divided into group A (mifepristone 12.5 mg, qd, 3 months) and group B (gestrinone 2.5 mg, twice a week, 3 months). The therapeutic efficacy and adverse drug reactions were compared between 2 groups. RESULTS: The remission rate and improvement rate of group A were similar to those of group B(P>0.05). But the r...
Keywords:Laparoscopy  Endometriosis surgery  Gestrinone  Mifepristone  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号